Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To investigate whether tiotropium (Spiriva) improves exercise endurance in patients with COPD

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Bromides; Tiotropium Bromide